Lymph node thyroglobulin in the diagnosis of metastases of thyroid carcinoma with the thyroid in situ: A prospective intraoperative study.


Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
04 2023
Historique:
received: 11 11 2022
revised: 04 12 2022
accepted: 15 12 2022
medline: 28 3 2023
pubmed: 24 12 2022
entrez: 23 12 2022
Statut: ppublish

Résumé

The use of thyroglobulin concentration in washout fluid of fine-needle aspiration (FNA-Tg) is a procedure advocated by international guidelines to diagnose metastatic LN in papillary thyroid cancer. With the increasing use of active follow-up or lobectomy alone for low-risk thyroid cancers, the determination of the diagnostic performance of FNA-Tg in the detection of metastatic PTC when the thyroid is in situ is paramount. Prospective study with measurement of Tg in washout fluid obtained from intraoperative fine needle aspiration (FNA) cytology in order to avoid contamination from thyroid tissue and rigorously isolated punctured nodes. Receiver-operating characteristic (ROC) curve and area under the curve (AUC), optimal threshold to discriminate benign and malignant LN, sensitivity and specificity were provided. a total of 58 lymph nodes from 32 patients were analyzed. ROC analysis defined the optimal cutoff values of FNA-Tg at 60 ng/ml for the diagnosis of malignant LNs in patients with a thyroid in situ. Sensitivity and specificity were 75% (95% confidence interval 57.89-86.75) and 87.5% (95%CI: 69-95.66), respectively. Our results support the hypothesis that the Tg-FNA threshold for a safe diagnosis of LN metastasis in PTC is higher in presence of a thyroid gland in situ. The use of lower thresholds could result in false positive results and lead to unnecessary surgery.

Sections du résumé

BACKGROUND
The use of thyroglobulin concentration in washout fluid of fine-needle aspiration (FNA-Tg) is a procedure advocated by international guidelines to diagnose metastatic LN in papillary thyroid cancer. With the increasing use of active follow-up or lobectomy alone for low-risk thyroid cancers, the determination of the diagnostic performance of FNA-Tg in the detection of metastatic PTC when the thyroid is in situ is paramount.
MATERIALS AND METHODS
Prospective study with measurement of Tg in washout fluid obtained from intraoperative fine needle aspiration (FNA) cytology in order to avoid contamination from thyroid tissue and rigorously isolated punctured nodes. Receiver-operating characteristic (ROC) curve and area under the curve (AUC), optimal threshold to discriminate benign and malignant LN, sensitivity and specificity were provided.
RESULTS
a total of 58 lymph nodes from 32 patients were analyzed. ROC analysis defined the optimal cutoff values of FNA-Tg at 60 ng/ml for the diagnosis of malignant LNs in patients with a thyroid in situ. Sensitivity and specificity were 75% (95% confidence interval 57.89-86.75) and 87.5% (95%CI: 69-95.66), respectively.
CONCLUSION
Our results support the hypothesis that the Tg-FNA threshold for a safe diagnosis of LN metastasis in PTC is higher in presence of a thyroid gland in situ. The use of lower thresholds could result in false positive results and lead to unnecessary surgery.

Identifiants

pubmed: 36564333
pii: S0748-7983(22)01353-1
doi: 10.1016/j.ejso.2022.12.007
pii:
doi:

Substances chimiques

Thyroglobulin 9010-34-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

760-763

Informations de copyright

Copyright © 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Auteurs

Santa D'angeli (S)

Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, France.

Nunzia Cinzia Paladino (NC)

Department of Endocrine Surgery, Conception University Hospital, Aix-Marseille University, France.

Christelle Fargette (C)

Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, France.

Cendrine Archange (C)

Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, France.

Wassim Essamet (W)

Department of Neuropathology, La Timone University Hospital, Aix-Marseille University, Marseille, France.

Zeinab Hamidou (Z)

Department of Public Health, Aix-Marseille University, Marseille, France.

Fausto Palazzo (F)

Department of Endocrine & Thyroid Surgery, Imperial College London, London, UK.

Karine Baumstarck (K)

Department of Public Health, Aix-Marseille University, Marseille, France.

Frédéric Sebag (F)

Department of Endocrine Surgery, Conception University Hospital, Aix-Marseille University, France.

David Taïeb (D)

Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, France. Electronic address: david.taieb@ap-hm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH